Chief Executive Officer
Dr Damien Bates is a seasoned biopharma executive who has managed global teams across all phases of the product development lifecycle.
He has held leadership positions in large, diversified healthcare companies such as Baxter and Allergan as well as in smaller biotechnology companies such as Organogenesis, SanBio and BioCurate. He was instrumental in value creation for these companies through successful execution of preclinical studies to IND, late-stage clinical trials, and also taking products through to FDA approval.
Damien received his medical degree from the University of Sydney, his PhD in Developmental Biology from the University of Melbourne, his Fellowship in Plastic & Reconstructive Surgery from the Royal Australasian College of Surgeons, and his MBA from the Wharton Business School.